Latest Insider Transactions at Cytek Biosciences, Inc. (CTKB)
This section provides a real-time view of insider transactions for Cytek Biosciences, Inc. (CTKB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cytek Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cytek Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 27
2021
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
2,950,000
+19.76%
|
$50,150,000
$17.0 P/Share
|
|
Jul 22
2021
|
Wenbin Jiang PRESIDENT AND CEO |
BUY
Conversion of derivative security
|
Indirect |
2,666,600
+50.0%
|
-
|
|
Jul 22
2021
|
Feng Deng Director |
BUY
Conversion of derivative security
|
Indirect |
4,760,510
+50.0%
|
-
|
|
Jul 22
2021
|
Allen Poirson SVP BUS. AND CORP. DEV. |
BUY
Open market or private purchase
|
Direct |
1,500
+3.58%
|
$25,500
$17.0 P/Share
|
|
Jul 22
2021
|
Gisele Dion Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$85,000
$17.0 P/Share
|
|
Jul 22
2021
|
Jack Ball |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$51,000
$17.0 P/Share
|
|
Jul 22
2021
|
Valerie Barnett CHIEF LEGAL OFFICER |
BUY
Open market or private purchase
|
Direct |
1,900
+50.0%
|
$32,300
$17.0 P/Share
|